Wealthspire Advisors (Maryland)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-527
| Closed | -$71K | – | 2389 |
|
|
2019
Q1 | $71K | Buy |
527
+60
| +13% | +$8.08K | 0.01% | 768 |
|
|
2018
Q4 | $45K | Sell |
467
-254
| -35% | -$24.5K | ﹤0.01% | 905 |
|
|
2018
Q3 | $100K | Buy |
721
+16
| +2% | +$2.22K | 0.01% | 686 |
|
|
2018
Q2 | $88K | Buy |
705
+57
| +9% | +$7.12K | 0.01% | 755 |
|
|
2018
Q1 | $72K | Sell |
648
-53
| -8% | -$5.89K | 0.01% | 843 |
|
|
2017
Q4 | $84K | Buy |
701
+19
| +3% | +$2.28K | 0.01% | 784 |
|
|
2017
Q3 | $96K | Buy |
682
+29
| +4% | +$4.08K | 0.01% | 729 |
|
|
2017
Q2 | $79K | Buy |
653
+104
| +19% | +$12.6K | 0.01% | 790 |
|
|
2017
Q1 | $67K | Sell |
549
-327
| -37% | -$39.9K | 0.01% | 721 |
|
|
2016
Q4 | $107K | Buy |
876
+132
| +18% | +$16.1K | 0.02% | 557 |
|
|
2016
Q3 | $91K | Sell |
744
-15
| -2% | -$1.84K | 0.01% | 596 |
|
|
2016
Q2 | $89K | Buy |
759
+11
| +1% | +$1.29K | 0.01% | 554 |
|
|
2016
Q1 | $104K | Buy |
748
+25
| +3% | +$3.48K | 0.02% | 514 |
|
|
2015
Q4 | $138K | Buy |
+723
| New | +$138K | 0.03% | 455 |
|